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Elective Chronic Total
Coronary Occlusion
AngioplastyIn the paper by George et al. (1), regarding the clinical
outcome after chronic total occlusion (CTO) percu-
taneous coronary intervention (PCI), the methods
have been described with insufﬁcient details and no
data are provided about the indication to PCI and the
viability of the myocardial territory supplied by the
CTO vessel (1). Moreover, beyond the characteristics
of the medical treatment after PCI that were un-
known, patients with successful PCI had nonuniform
procedural treatment with a substantial minority of
patients receiving bare-metal stents or no stent. All
these variables might have confounded the results
considering the strong impact on survival of optimal
medical treatment and drug-eluting stents after CTO
PCI. The authors revealed a survival beneﬁt after CTO
PCI success, and a greater survival improvement in
patients who received a complete revascularization.
It should have been outlined that patients with a
CTO and single-vessel disease have a very low mor-
tality rate and it is likely that the outcome cannot
be improved by successful PCI. Conversely, the
beneﬁt of a complete revascularization is easily
revealed in patients with at least 1 CTO and multi-
vessel disease. The link between completeness of
revascularization and improved survival just in pa-
tients with CTO and multivessel disease was already
demonstrated by 2 key studies that are not com-
mented on or quoted by the authors (2,3). Finally, it
seems unlikely that the ongoing EuroCTO (European
Chronic Total Occlusion) study comparing CTO PCIwith optimal medical therapy alone will deﬁnitely
support the indication to CTO revascularization,
considering the very low enrollment rate of this
study and the subsequent biased patient selection,
and the strong rationale of revascularization of
a CTO vessel supplying a large amount of viable
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2013;61:282–94.REPLY: Long-Term Follow-Up of Elective
Chronic Total Coronary Occlusion AngioplastyWe thank the readers of the Journal for their
thoughtful comments about our paper (1). We carried
out a retrospective analysis of registry data concern-
ing chronic total occlusion (CTO) procedures. In
keeping with other International Procedural Regis-
tries, no data exist in the British Cardiovascular
Intervention Society dataset for patients in whom
revascularization was not attempted. In view of this,
we have been careful not to attribute causality; we
have simply described the association. This was not a
randomized trial.
Dr. Huqi and colleagues suggest that our work is
consistent with previous work by Boden et al. (2),
which examined medical management versus percu-
taneous coronary intervention (PCI). That study is not
representative of our patient population, as they
excluded patients whose coronary anatomy was not
considered suitable for successful PCI (as is the case
